ライフサイエンスコーパス: intravenously

1 llowing cocaine administration (1 mg kg(-1), intravenously).

2 noconjugate gemtuzumab ozogamicin (6 mg/m(2) intravenously).

3 en MSCs are injected endotracheally (but not intravenously).

4 nuate systemic bacterial burden administered intravenously.

5 Contrast agent was administrated intravenously.

6 lung colonies than fs188 cells when injected intravenously.

7 ll loaded with PTX were weekly administrated intravenously.

8 quired pneumonia (CAP) generally are treated intravenously.

9 ced, centrally mediated analgesia when given intravenously.

10 iodinated contrast media (ICM) administered intravenously.

11 inistered with the drug at a 7.5 mg/kg dose, intravenously.

12 tine or bendamustine monotherapy, both given intravenously.

13 ished FUS technique where drugs are injected intravenously.

14 mab (1000 mg once every 4 weeks), also given intravenously.

15 ation, and can be more feasibly administered intravenously.

16 ne 4T1 breast cancer model when administered intravenously.

17 ethyl-6-O-glycolchitosan (GCPQ) and injected intravenously.

18 rown chronically at 5% O2, were administered intravenously.

19 ia induction, indocyanine green was injected intravenously.

20 sion in which they self-administered alcohol intravenously.

21 All treatments were administered intravenously.

22 m(2); maximum, 20 mCi]) of (11)C-methionine intravenously.

23 Both groups received albumin intravenously 1 g/kg of body weight on day 1 and 20-40 g

24 eived either a saline or citalopram infusion intravenously (10 mg over 30 min) on separate occasions

25 0 mg per kilogram), or placebo, administered intravenously 14 times over a period of 52 weeks.

26 of unfractionated heparin were administered intravenously 15 min before (18)F-FDG injection.

27 ly improved renal function when administered intravenously 24 and 48 hours after renal ischemia in ra

28 saline infused intracerebroventricularly or intravenously 24 hours after injury.

29 Mice received 2x10(6) MSCs or saline intravenously 24 hours post-myocardial infarction (n=16

30 am of body weight of indocyanine green (ICG) intravenously 24 hours prior to their scheduled procedur

31 orresponding radiolabeled probe was injected intravenously 30 min later, followed by sequential PET o

32 (89)Zr-bevacizumab (37 MBq) was administered intravenously 4 d before the scan.

33 /kg intravenously twice daily on day 2, then intravenously 4 mg/kg twice daily or orally 200 mg twice

34 ses of IFN-alpha-2b 20 MIU/m(2) administered intravenously 5 days a week for 4 weeks then repeated ev

35 ipants received sodium thiosulfate 16 g/m(2) intravenously 6 h after each cisplatin dose or observati

36 ) with centre stratification to receive A1PI intravenously 60 mg/kg per week or placebo for 24 months

37 on of gemcitabine (1000 mg/m(2) days 1 and 8 intravenously, 75 mg/m(2) docetaxel), all followed by ne

38 Intravenously administered 182-SNAs penetrated the blood

39 with an indeterminate pulmonary nodule were intravenously administered a folate receptor-targeted fl

40 s untreatable due to poor biodistribution of intravenously administered anticancer drugs to bone.

41 Our pharmacokinetic studies revealed that intravenously administered BTNPs increased circulation t

42 usly administered epirubicin and 600 mg/m(2) intravenously administered cyclophosphamide on day 1 eve

43 approximately 10mm Hg increased the entry of intravenously administered dexamethasone at the injury s

44 rum and delivery in a tumor-targeted manner, intravenously administered Dual-poly-siRNA carrying glyc

45 e, and paclitaxel (four cycles of 90 mg/m(2) intravenously administered epirubicin and 600 mg/m(2) in

46 aneous device that measures the half-life of intravenously administered FITC-sinistrin, a molecule cl

47 Intravenously administered free DOX does not effectively

48 When regulatory T cells (2 x 106/mouse) were intravenously administered immediately after delayed tPA

49 ssess the safety and preliminary efficacy of intravenously administered ischemia-tolerant MSCs (itMSC

50 Patients were randomized to intravenously administered itMSCs (1.5x10(6) cells/kg) o

51 fteen years, focused ultrasound coupled with intravenously administered microbubbles (FUS) has been p

52 Because few intravenously administered MSCs engraft in the myocardiu

53 Intravenously administered MSCs for acute myocardial inf

54 To test whether intravenously administered MSCs reduce left ventricular

55 t an opportunity for passive accumulation of intravenously administered nanomedicines in many patholo

56 expression in tumor vasculature and inhibits intravenously administered oncolytic vaccinia delivery t

57 When intravenously administered to a mouse model of cardiovas

58 fluorescent protein (GFP) reporter gene were intravenously administered to fetal and neonatal mice, w

59 Radiochemically isolated (51)MnCl2 was intravenously administered to ICR mice which were scanne

60 ally patients for such an approach, AAV9 was intravenously administered to late-gestation NHPs by usi

61 en received weekly doses of custirsen 640 mg intravenously after three loading doses of 640 mg.

62 with inhibitor or had inhibitor administered intravenously after transplantation.

63 rgdorferi in which the bacteria are injected intravenously and allowed to circulate for 1 h.

64 Most often they are used intravenously and intraarterially.

65 Etelcalcetide intravenously and oral placebo (n = 340) or oral cinacal

66 These experiments examined the effects of intravenously and orally administered buspirone, a D2-li

67 days 1 to 7 along with irinotecan 50 mg/m(2) intravenously and temozolomide 100 mg/m(2) orally on day

68 All patients received granisetron (10 mug/kg intravenously) and dexamethasone (20 mg orally) on day 1

69 ly) or placebo, with bortezomib (1.3 mg/m(2) intravenously) and dexamethasone (20 mg orally), over tw

70 4 h, (68)Ga-NOTA-UBI-29-41 was administrated intravenously, and biodistribution was performed at 30,

71 abine to the paclitaxel cycles, administered intravenously as a 0.5 h infusion on days 1 and 8 every

72 eno-associated viral (rAAV) vectors injected intravenously as a route to systemic gene therapy.

73 on with 100 mL of contrast material injected intravenously as a single bolus; or protocol B, 100 mL o

74 chloride thrombosis model when administered intravenously as parent or orally as its prodrug 45.

75 c trioxide group, arsenic trioxide was given intravenously at 0.3 mg/kg on days 1-5 of each course, a

76 Alemtuzumab was given intravenously at 10 mg per day for 10 days.

77 Ib trial of single-agent pembrolizumab given intravenously at 10 mg/kg every 2 weeks to patients with

78 A and idarubicin group, idarubicin was given intravenously at 12 mg/m(2) on days 2, 4, 6, and 8 of co

79 ay orally or placebo plus weekly trastuzumab intravenously at 4 mg/kg loading dose on day 1 with subs

80 one tracer while a second tracer is infused intravenously at a constant rate.

81 t therapy with sebelipase alfa (administered intravenously at a dose of 1 mg per kilogram of body wei

82 Pembrolizumab was administered intravenously at a dose of 10 mg per kilogram of body we

83 Avelumab was given intravenously at a dose of 10 mg/kg every 2 weeks.

84 m to receive either paclitaxel, administered intravenously at a dose of 175 mg per square meter of bo

85 % or more to receive nivolumab (administered intravenously at a dose of 3 mg per kilogram of body wei

86 2 mg/kg of each 4 week cycle plus paclitaxel intravenously at a dose of 80 mg/m(2) on days 1, 8, and

87 Given intravenously at reperfusion/resuscitation to rats, ATTM

88 to groups given MEDI2070 (700 mg) or placebo intravenously at weeks 0 and 4.

89 (3)H-cholesteryl oleate-labeled LDL injected intravenously by 20%, indicating that empagliflozin rais

90 mg/m(2) intravenously; cisplatin 60 mg/m(2) intravenously; capecitabine 625 mg/m(2) orally twice dai

91 round) were intraperitoneally sensitized and intravenously challenged with S. mansoni eggs to induce

92 en-label chemotherapy (epirubicin 50 mg/m(2) intravenously; cisplatin 60 mg/m(2) intravenously; capec

93 cal analysis, we found that EVT901 delivered intravenously daily for 1 week after injury, reduced les

94 ubcutaneously daily or decitabine 20 mg/m(2) intravenously daily for 3 consecutive days on a 28-day c

95 signed 1:1 to receive doxorubicin 75 mg/m(2) intravenously day 1 plus palifosfamide 150 mg/m(2)/d int

96 ously day 1 plus palifosfamide 150 mg/m(2)/d intravenously days 1 to 3 or doxorubicin plus placebo on

97 The quantum dots are intravenously delivered into orthotopic breast and pancr

98 could ultimately enhance clinical utility of intravenously delivered nanoscale medicines including vi

99 ver, these agents are limited when delivered intravenously due to their rapid clearance from the bloo

100 e neoadjuvant CT-P6 or reference trastuzumab intravenously (eight cycles, each lasting 3 weeks, for 2

101 every 3 to 4 weeks; or zoledronic acid, 4 mg intravenously every 12 weeks or every 3 to 4 weeks.

102 n randomly assigned 2:1 to nivolumab 3 mg/kg intravenously every 2 weeks or investigator's choice che

103 iomarker analysis received nivolumab 3 mg/kg intravenously every 2 weeks until disease progression an

104 Patients received nivolumab 3 mg/kg intravenously every 2 weeks until disease progression or

105 ifty-two patients received nivolumab 3 mg/kg intravenously every 2 weeks until progression or unaccep

106 oral once per day plus bevacizumab 10 mg/kg intravenously every 2 weeks.

107 Patients received pembrolizumab 10 mg/kg intravenously every 2 weeks.

108 PD-L1 expression received avelumab 10 mg/kg intravenously every 2 weeks.

109 axel plus prednisone (cabazitaxel 25 mg/m(2) intravenously every 21 days plus oral prednisone 10 mg d

110 acizumab group received bevacizumab 15 mg/kg intravenously every 21 days starting with cycle 1 of che

111 to receive trastuzumab emtansine (3.6 mg/kg intravenously every 21 days) or treatment of physician's

112 2; cycles 2-6: 1000 mg/m(2) on day 1) given intravenously every 21 days.

113 citabine 1250 mg/m(2) on days 1 and 8) given intravenously every 3 weeks for a maximum of eight cycle

114 Ipilimumab (3 mg/kg) was administered intravenously every 3 weeks for four infusions, beginnin

115 5 mg/kg to 0.8 mg/kg rovalpituzumab tesirine intravenously every 3 weeks or every 6 weeks, followed b

116 y assigned 1:1:1 to receive C20, C25, or D75 intravenously every 3 weeks plus daily prednisone.

117 e system to trastuzumab emtansine (3.6 mg/kg intravenously every 3 weeks) or control (capecitabine 10

118 en plus bevacizumab 7.5 mg per kg bodyweight intravenously every 3 weeks, given concurrently and cont

119 Nivolumab 0.3, 2, or 10 mg/kg intravenously every 3 weeks.

120 ratio to receive trabectedin or dacarbazine intravenously every 3 weeks.

121 itaxel 175 mg/m(2), or 75 mg/m(2) docetaxel) intravenously every 3 weeks.

122 ally twice daily or dacarbazine 1000 mg/m(2) intravenously every 3 weeks.

123 ized to receive zoledronic acid administered intravenously every 4 weeks (n = 911) vs every 12 weeks

124 Tocilizumab was given at 8 mg/kg intravenously every 4 weeks with a maximum of 800 mg per

125 ed that, if available, zoledronic acid (4 mg intravenously every 6 months) or clodronate (1,600 mg/d

126 ients received nivolumab (3 mg/kg bodyweight intravenously) every 2 weeks (given until disease progre

127 mg/kg plus 3 mg/kg, or 3 mg/kg plus 1 mg/kg, intravenously) every 3 weeks for four cycles, followed b

128 cyclophosphamide (60 mg/m(2) and 600 mg/m(2) intravenously) every 3 weeks for four cycles.

129 taneously, every 4 weeks; pamidronate, 90 mg intravenously, every 3 to 4 weeks; or zoledronic acid, 4

130 received 148-444 MBq (4-12mCi) of (18)F-MFBG intravenously followed by serial whole-body imaging at 0

131 ubjects: 17 subjects received ATG (2.5 mg/kg intravenously) followed by pegylated G-CSF (6 mg subcuta

132 RANTES-NIS-MSCs were injected intravenously, followed by (123)I scintigraphy, (124)I P

133 l administered concurrently with trastuzumab intravenously for 12 weeks, followed by trastuzumab mono

134 se procedure) plus evofosfamide (300 mg/m(2) intravenously for 30-60 min on days 1 and 8 of every 21-

135 ery 8 hours or meropenem (1 g) every 8 hours intravenously for 4-14 days.

136 36, 10 mg/kg every 2 weeks) was administered intravenously for up to 12 months.

137 with high-dose methylprednisolone (1 g/day, intravenously, for 3-5 days), participants were assigned

138 The animals were intravenously (i.v.) administered PGT121 or 3BNC117 at 1

139 -vorozole (111-296 MBq/subject) was injected intravenously in 13 men and 20 women (age range, 23-67 y

140 reuptake inhibitor (SSRI) citalopram (10 mg) intravenously in a double-blind crossover design.

141 erfluorocarbon (PFC) emulsions were injected intravenously in a mouse model of atherosclerosis (n = 1

142 lipid nanoparticles (LNPs), was administered intravenously in adult mice.

143 cell lines and can be effectively delivered intravenously in an orthotopic GBM mouse model.

144 Rituximab 375 mg/m(2) was given intravenously in both groups on day 0 of cycle 1 and sub

145 000 mg, twice daily) vs placebo administered intravenously in cases of pure or mixed metabolic alkalo

146 ld, patient's metastatic tumor extract given intravenously in dogs, produced significantly increased

147 We injected 11C-Pittsburgh compound B (PIB) intravenously in transgenic and control APP23 mice and p

148 ce daily continuously plus ofatumumab 300 mg intravenously in week 1, then 1000 mg intravenously week

149 omal cells and derived vesicles administered intravenously induced morphologic and functional recover

150 er simulation to demonstrate that RAG-2 mice intravenously infected with Leishmania donovani form het

151 HbSS and C57BL/6 (control) mice intravenously infected with S. pneumoniae were treated i

152 Here we intravenously infuse two AAVs, one expressing Cas9 and t

153 with 6 mg (57)Fe as ferrous sulfate and were intravenously infused with 100 mug (58)Fe as iron citrat

154 as (HIP rats) and amylin knockout (AKO) rats intravenously infused with aggregated amylin were used f

155 In a first set of mice (n = 15), we intravenously injected (3)H-cholesteryl oleate-labeled h

156 old in the 1950s with the demonstration that intravenously injected bone marrow cells can rescue irra

157 Intravenously injected DAG peptide homes to neurovascula

158 systemic vasculature as they are perfused by intravenously injected dye.

159 We detected prominent binding of intravenously injected F-Dapa in the kidney cortexes of

160 Additionally, intravenously injected F. nucleatum localizes to mouse t

161 Intravenously injected FAM-labeled UNO (FAM-UNO) homed t

162 Intravenously injected iNPG-pDox accumulates at tumors d

163 ain (ABD), were radiolabeled with (125)I and intravenously injected into immunocompromised mice beari

164 When nanoparticles are intravenously injected into the body, complement protein

165 -CF was transported through permeable TJ, we intravenously injected low molecular weight (3 kDa) dext

166 A method for targeting to and retaining intravenously injected nanoparticles at the site of acut

167 Intravenously injected nanopharmaceuticals, including PE

168 mmunophenotypic analysis of lung tumor cells intravenously injected or spontaneously disseminated to

169 oblasts (FB-rhC7), we showed previously that intravenously injected rhC7 distributed to engrafted RDE

170 Intravenously injected S100A4 protein induced expression

171 tion time allow for capturing the flow of an intravenously injected tracer through the heart of a mou

172 Animals were intravenously injected with (64)Cu-GTSM and imaged at 0-

173 sed from previous studies in which mice were intravenously injected with 0.064-42 kBq of (211)At and

174 to -4A chimera RNA for primary infection or intravenously injected with chimera-containing serum for

175 ne the direct effect of L5 on QTc, mice were intravenously injected with L5 or L1.

176 Sub-acute toxicology performed on rats intravenously injected with Mangradex at 1, 50 or 100 mg

177 Tumour xenografts in mice intravenously injected with nanoparticles using a high-d

178 Neonate mice intravenously injected with the AAV-BR1-CAG-NEMO vector

179 ition, cognition was tested in AD model mice intravenously injected with young blood plasma.

180 exogenous magnetic resonance contrast agent intravenously injected.

181 FX mediates hepatocyte transduction by intravenously-injected Ad5 vectors and shields vector pa

182 and biodisposition studies were performed by intravenously injecting three types of (198)Au-GNPs with

183 tumor-targeted bioimaging performance after intravenously injection into mice, but not the rod-like

184 lus a new malaria control group (n = 8) were intravenously inoculated with 10(5) Plasmodium knowlesi

185 nfection, was assessed in macaques that were intravenously inoculated with the same viral swarm and a

186 etate under reducing conditions and injected intravenously into CAIX-expressing SKRC-52 xenograft-bea

187 single dose of human native LDL was injected intravenously into male C57BL/6 mice with and without NA

188 In in vivo study, p-XSC was injected intravenously into mice and plasma was collected for LC-

189 by simple heat treatment, and when injected intravenously into mice, the small nanofibers can specif

190 A single dose of CHO-rhC7, administered intravenously into new-born C7-null RDEB mice, incorpora

191 P-483 were labeled with (111)In and injected intravenously into NTR1-positive HT29 xenograft-bearing

192 with Alexa750 or (64)Cu-NODAGA and injected intravenously into separate cohorts of nude mice bearing

193 lected before randomisation and administered intravenously; it consisted of four 21-day cycles of cis

194 An intravenously (IV) administered calcimimetic could impro

195 gned (1:1:1) to receive docetaxel 75 mg/m(2) intravenously (IV) on day 1 of a 3-week cycle (arm A), d

196 local chemoattractants to enhance homing of intravenously (IV)-infused MSC and improve outcomes.

197 y to arm A (bevacizumab monotherapy 10 mg/kg intravenously [IV] every 2 weeks), B (bevacizumab 10 mg/

198 Neoadjuvant gemcitabine (1,000 mg/m(2) intravenously [IV] on days 1 and 8), carboplatin (area u

199 eceive either mDCF (fluorouracil 2,000 mg/m2 intravenously [IV] over 48 hours, docetaxel 40 mg/m2 IV

200 hat detoxification of stepwise increments of intravenously (jugular vein) infused ammonia is almost t

201 epolizumab ( DREAM: 75 mg, 250 mg, or 750 mg intravenously; MENSA: 75 mg intravenously or 100 mg subc

202 nine patients received single-dose BI 655066 intravenously (n = 18) or subcutaneously (n = 13) or pla

203 Lorazepam (3 mg) intravenously (n = 47) or placebo (n = 43) in addition t

204 nded phase 2 dose (RP2D) of MRZ administered intravenously on 2 different schedules: schedule A (0.02

205 receive six to eight 21-day cycles of R-CHOP intravenously on day 1 (with prednisone administered ora

206 atio to receive either olaratumab (15 mg/kg) intravenously on day 1 and day 8 plus doxorubicin (75 mg

207 All patients received 400 mg intravenously on day 1 and were permitted to switch to o

208 .2 mg/kg or 1.8 mg/kg of brentuximab vedotin intravenously on day 1 of a 21 day cycle, plus one dose

209 chedule as above) and rituximab (375 mg/m(2) intravenously on day 1 of weeks 1, 2, 3, 4, 9, 13, 17, a

210 four treatment groups: cisplatin (50 mg/m(2) intravenously on day 1 or 2 of the treatment cycle) and

211 ay 1), with or without bevacizumab (15 mg/kg intravenously on day 1 or 2), or paclitaxel (175 mg/m(2)

212 reatment was (131)I-MIBG (444 or 666 MBq/kg) intravenously on day 1 plus arsenic trioxide (0.15 or 0.

213 (2) [dose dependent on centre and clinician] intravenously on day 1) every 21 days until disease prog

214 or dacarbazine (850, 1,000, or 1,200 mg/m(2) intravenously on day 1) every 21 days.

215 s 1-3) with or without bevacizumab (15 mg/kg intravenously on day 1).

216 icin [50 mg/m(2)] and cisplatin [60 mg/m(2)] intravenously on day 1, and capecitabine [1250 mg/m(2)]

217 nclusion forming units (IFU) W. chondrophila intravenously on day 105-110 of pregnancy, while four ne

218 two 3-weekly cycles of cisplatin [80 mg/m(2) intravenously on day 1] and fluorouracil [1 g/m(2) per d

219 imum of six cycles (bendamustine: 70 mg/m(2) intravenously on days 1 and 2 for six 28-day cycles; rit

220 alone or R-CHOP plus bortezomib 1.3 mg/m(2) intravenously on days 1 and 4 (VR-CHOP).

221 ndomly assigned 1:1 to vosaroxin (90 mg/m(2) intravenously on days 1 and 4 in a first cycle; 70 mg/m(

222 n days 1 and 8; and 600 mg/m(2) fluorouracil intravenously on days 1 and 8 of each cycle) or four 3-w

223 orouracil (CMF; 600 mg/m(2) cyclophosphamide intravenously on days 1 and 8 or 100 mg/m(2) orally on d

224 ed four cycles of gemcitabine (1,000 mg/m(2) intravenously on days 1 and 8) and capecitabine (1,500 m

225 ts to receive eribulin mesilate (1.4 mg/m(2) intravenously on days 1 and 8) or dacarbazine (850 mg/m(

226 :1 to receive eribulin mesylate (1.4 mg/m(2) intravenously on days 1 and 8) or dacarbazine (850, 1,00

227 orally on days 1-14; 40 mg/m(2) methotrexate intravenously on days 1 and 8; and 600 mg/m(2) fluoroura

228 ycles of bortezomib (each cycle: 1.3 mg/m(2) intravenously on days 1, 4, 8, and 11) prevent GFR decli

229 Bortezomib was given at 1.3 mg/m(2) intravenously on days 1, 4, 8, and 11, combined with ora

230 bumin bound paclitaxel, 100 mg/m2, was given intravenously on days 1, 8, and 15, and repeated every 2

231 mg daily) with or without custirsen (640 mg intravenously on days 1, 8, and 15, plus three previous

232 on day 1] and fluorouracil [1 g/m(2) per day intravenously on days 1-4]) or four cycles of epirubicin

233 subsequent cycles) plus cytarabine (1 g/m(2) intravenously on days 1-5) or placebo plus cytarabine th

234 4 weeks' duration (bendamustine: 70 mg/m(2) intravenously on days 2-3 in cycle 1, and days 1-2 in cy

235 plus arsenic trioxide (0.15 or 0.25 mg/m(2)) intravenously on days 6-10 and 13-17.

236 mg of imetelstat per kilogram of body weight intravenously once a week until attainment of a platelet

237 receive placebo or active drug administered intravenously once every 3 weeks for a total of eight in

238 b (15 mg/kg) plus fosbretabulin (60 mg/m(2)) intravenously once every 3 weeks until disease progressi

239 e randomly assigned to bevacizumab (15 mg/kg intravenously once every 3 weeks) or the combination of

240 r day) with or without bevacizumab (15 mg/kg intravenously once every 3 weeks) within strata defined

241 o of 1:1:1) to nivolumab 0.3, 2, or 10 mg/kg intravenously once every 3 weeks.

242 Rituximab 375 mg/m(2) was given intravenously once per week for 4 weeks during cycle 1,

243 All consecutive patients received 75 mg intravenously once per week.

244 t cohort (n = 6) received 25 mg temsirolimus intravenously once per week.

245 50 mg, or 750 mg intravenously; MENSA: 75 mg intravenously or 100 mg subcutaneously) versus placebo w

246 ing human amniotic mesenchymal stromal cells intravenously or intracerebroventricularly showed early

247 y route when the drug is administered either intravenously or intraperitoneally, as well as the subse

248 ree times a day on days 1 and 2, then either intravenously or orally once daily) or voriconazole (6 m

249 ponse system to receive rilotumumab 15 mg/kg intravenously or placebo in combination with open-label

250 ponse system to receive 100 mg/kg opicinumab intravenously or placebo once every 4 weeks (six doses)

251 mg twice daily) plus paclitaxel (80 mg/m(2) intravenously) or matching placebo plus paclitaxel.

252 fficient doses of (177)Lu-DOTATATE (7.5 MBq, intravenously) or the nicotineamide phosphoribosyltransf

253 ke of (59)Fe administered by gastric gavage, intravenously, or intraperitoneally was significantly lo

254 otics, or synbiotics; were delivered orally, intravenously, or per rectum; were on biomarkers of syst

255 d photodynamic therapy (4 mg/kg padeliporfin intravenously over 10 min and optical fibres inserted in

256 cycle and cisplatin 75 mg/m(2) administered intravenously over 120 min on day 1 of a 3-week cycle.

257 treatment cycle) and paclitaxel (135 mg/m(2) intravenously over 24 h or 175 mg/m(2) intravenously ove

258 We gave a total dose of ATG of 4.5 mg/kg intravenously over 3 days (0.5 mg/kg 2 days before trans

259 /m(2) intravenously over 24 h or 175 mg/m(2) intravenously over 3 h on day 1), with or without bevaci

260 nd instead received melphalan at 200 mg/m(2) intravenously over 30 min on 1 day, followed by ASCT (co

261 py was gemcitabine 1250 mg/m(2) administered intravenously over 30 min on days 1 and 8 of a 3-week cy

262 (15 mg/150 ml of normal saline administered intravenously over 30 min) in medication-free patients w

263 Patients were given nivolumab intravenously over 60 min at 3 mg/kg every 2 weeks until

264 Necitumumab 800 mg, administered intravenously over a minimum of 50 min on days 1 and 8,

265 istered once per week at a dose of 6 mg/m(2) intravenously over a period of 70 weeks.

266 radermally and 20 x 10(6) cells administered intravenously) plus ipilimumab (10 mg/kg every 3 weeks f

267 When administered intravenously, PpZEV NPs rapidly accumulated in the live

268 Patients were randomly assigned (1:1) to intravenously receive either atezolizumab 1200 mg or doc

269 Thirteen weeks old G93A mice intravenously received one of three different doses of h

270 lthood, they were tested by allowing them to intravenously self-administer the cannabinoid CB1-recept

271 ed flavor (i.e., taste and odor) aversion to intravenously self-administered (IVSA) nicotine, and tha

272 ign to receive either azacitidine 75 mg/m(2) intravenously/subcutaneously daily or decitabine 20 mg/m

273 ab for 1 year (once at 8 mg/kg of bodyweight intravenously, then 6 mg/kg once every 3 weeks) or for 2

274 prodrug; equivalent to 200 mg isavuconazole; intravenously three times a day on days 1 and 2, then ei

275 mAbs and challenged with trinitrophenyl-BSA intravenously to induce systemic anaphylaxis that was mo

276 ion and enhance shelf-life, and administered intravenously to mimic, leverage, and amplify physiologi

277 tigational drug, nivolumab, was administered intravenously to study participants over a 60-minute per

278 without ketamine (3 mg kg(-1)) administered intravenously to the fetus 10 min prior to hypoxia.

279 th MRSA bacteremia received vancomycin 1.5 g intravenously twice daily and were randomly assigned (1:

280 orally once daily) or voriconazole (6 mg/kg intravenously twice daily on day 1, 4 mg/kg intravenousl

281 intravenously twice daily on day 1, 4 mg/kg intravenously twice daily on day 2, then intravenously 4

282 o (n = 43) in addition to haloperidol (2 mg) intravenously upon the onset of an agitation episode.

283 therapy, which can be administered orally or intravenously via a peripherally inserted central cathet

284 Ketamine (0.5 mg kg(-1) intravenously) was administered to 11 depressed patients

285 300 mg intravenously in week 1, then 1000 mg intravenously weekly for 7 weeks, and every 4 weeks for

286 Five healthy volunteers were injected intravenously with 232.4 +/- 1.5 MBq of (18)F-clofarabin

287 thods: Five healthy volunteers were injected intravenously with 232.4 +/- 1.5 MBq of (18)F-clofarabin

288 All patients received docetaxel 75 mg/m(2) intravenously with 5 mg of prednisone orally twice daily

289 Five multiple-myeloma patients were injected intravenously with 90-158 MBq of (68)Ga-pentixafor (mean

290 liver X receptor (LXR) agonist, or injected intravenously with [(3) H]sitostanol- and [(14) C]choles

291 e gastrointestinal tract, we inoculated mice intravenously with a luciferase-expressing C. muridarum

292 Mice were injected intravenously with Cyclo/Dox or the vehicle two hours af

293 Furthermore, when hamsters are infected intravenously with HAdV-C6, live, infectious virus can b

294 ars) with focal breast lesions were injected intravenously with MBKDR (0.03 to 0.08 mL/kg of body wei

295 sly infected with S. pneumoniae were treated intravenously with PFCE or phosphate-buffered saline (PB

296 Fifteen athymic mice were treated intravenously with saline (n = 5) or with 5 or 7.5 mg of

297 ficient mice fed a Western diet and injected intravenously with the particles prepared as above biwee

298 varlilumab (0.1, 0.3, 1.0, 3.0, or 10 mg/kg intravenously) with a 28-day observation, followed by up

299 00 IU/kg) or placebo (isotonic saline, 0.9%) intravenously within 3 hours, at 12 to 18 hours, and at

300 on, 1 mL of isotonic saline was administered intravenously within sight of the volunteer during posit